Burgetová Ječmeňová Kateřina

Akademický titul: Mgr.

E-mail: katerina.jecmenova01@upol.cz

Telefon: 585632048

Skupiny: BAKALÁŘSKÝ STUDENT, DOKTORSKÝ STUDENT, IMTM, LEM, MAGISTERSKÝ STUDENT, PERSONÁL

Životopis

Drug resistance mechanisms in cancer

Specializace: Molekulární a translační medicína

Vedoucí: Džubák Petr M.D., Ph.D.

Stav: Ongoing od 2020.

Development and characterization of resistant cell lines to purine and pyrimidine cytotoxic drugs

Vedoucí: Džubák Petr M.D., Ph.D.

Stav: Absolvoval od 2018 do 2020.

Spectroscopic characteristics used drugs and their use in the identification of molecular targets

Vedoucí: Stanková Jarmila

Stav: Graduated od 2016 do 2018.

Ph.D. student specializing in molecular and cell biology, with a primary research focus on identifying and characterizing modulators of G protein-coupled receptors (GPCRs), particularly adenosine receptor agonists and antagonists. Possesses practical experience in cancer cell biology, molecular biology techniques, and high-throughput screening methodologies.

SINKEVICIUTE, U., K. BURGETOVÁ JEČMEŇOVÁ, S. GURSKÁ, L. POSTOVA SLAVETINSKA, V. BARAN, P. POLISHCHUK, P. DŽUBÁK, M. HOCEK, M. HAJDÚCH, M. TICHÝ

Synthesis and Biological Activity of 2,6-Disubstituted and 2,6,9-Trisubstituted 7-Deazapurine Nucleobases. ChemMedChem. 2026, 21(16), e70419, ISSN: 1860-7179, PMID: 42596056, PDF.

JURÁŠEK, M., E. DRABEROVA, J. ŘEHULKA, S. GURSKÁ, A. IVANOVA (NIKONENKO), P. POLISHCHUK, K. BURGETOVÁ JEČMEŇOVÁ, J. FAHNRICH, A. MARESOVA, J. TAUCHEN, A. REYES ROMERO, A. DÖMLING, M. HAJDÚCH, P. DRAŠAR, P. DRABER, P. DŽUBÁK

Colchicine-BODIPY Probes: Evidence for the Involvement of Intracellular Membranes in the Targeting of Colchicine to Tubulin. ACS pharmacology & translational science. 2025, 8(7), 1965-1985, ISSN: 2575-9108, PMID: 40672674, PDF.

ŘEHULKA, J., M. JURÁŠEK, P. DRABER, A. IVANOVA (NIKONENKO), S. GURSKÁ, K. BURGETOVÁ JEČMEŇOVÁ, O. MOKSHYNA, M. HAJDÚCH, P. POLISHCHUK, P. DRAŠAR, P. DŽUBÁK

Click estradiol dimers with novel aromatic bridging units: synthesis and anticancer evaluation. Journal of enzyme inhibition and medicinal chemistry. 2024, 39(1), 2367139, ISSN: 1475-6366 , PMID: 38904149, PDF.

Fialová Kateřina

Optimization of High-Throughput Screening for Potential Modulators of Purinergic Receptors

Stav: Absolvoval od 2024 do 2026.

Fialová Kateřina

siRNA knock-down of A3 adenosine receptor

Stav: Absolvoval od 2022 do 2024.

Burgetová Ječmeňová Kateřina

Doktorské studium

Magisterské studium

Bakalářské studium

O mně

Journals

Master mentorship

Fialová Kateřina

Bachelor mentorship

Fialová Kateřina